Doseology Sciences (XCNQ:MOOD) YoY EBITDA Growth : 43.75% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Doseology Sciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Doseology Sciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 43.75%.

Doseology Sciences's EBITDA per Share for the three months ended in Mar. 2024 was C$-0.01.

Doseology Sciences YoY EBITDA Growth Historical Data

The historical data trend for Doseology Sciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doseology Sciences YoY EBITDA Growth Chart

Doseology Sciences Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

YoY EBITDA Growth

-240.00

-23.53

7.26

Doseology Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial											86.44	-116.39	78.87	56.90	43.75

Doseology Sciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Doseology Sciences's YoY EBITDA Growth for the fiscal year that ended in Jun. 2023 is calculated as:

	YoY EBITDA Growth (A: Jun. 2023 )
=	(EBITDA per Share (A: Jun. 2023 )	-	EBITDA per Share (A: Jun. 2022 ))	/	\| EBITDA per Share (A: Jun. 2022 ) \|
=	(-0.409	-	-0.441)	/	\| -0.441 \|
=	7.26 %

Doseology Sciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.009	-	-0.016)	/	\| -0.016 \|
=	43.75 %

Doseology Sciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Doseology Sciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Doseology Sciences (XCNQ:MOOD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Doseology Sciences Inc (XCNQ:MOOD) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

DOSEF:USA

Address

116 - 5100 Anderson Way, Unit 197, Vernon, BC, CAN, V1T 0C4

Website

https://www.doseology.com

Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the aim of making a meaningful impact on the mental health pandemic and improving overall health.

Doseology Sciences (XCNQ:MOOD) Headlines

No Headlines